Compare HSBC Holdings plc (HSBC) vs Humana Inc (HUM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HSBC Holdings plc vs Humana Inc — how do they compare? HSBC Holdings plc trades at $101.13 (market cap $335.21B), while Humana Inc trades at $402.89 (market cap $47.81B). The key difference: HSBC Holdings plc is far larger — about 7× Humana Inc's market cap, and HSBC Holdings plc pays the higher dividend (3.79%). Which is the better fit depends on your goals.
| HSBC | HUM | |
|---|---|---|
Market Cap | $335.21B | $47.81B |
Sector | Technology | Health |
52-Week High | $100.61 | $409.42 |
52-Week Low | $61.30 | $163.67 |
Dividend Yield | 3.79% | 0.89% |
Enterprise Value | — | $56.85B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HSBC trades at $99.01, down 1.59% today but near its 52-week high of $99.47. The stock shows bullish technical momentum with strong moving average support and recent earnings beats in Q3 and Q4 2025. Revenue grew to $71.02B in 2025 with a healthy 30.81% net margin, though Q1 2026 missed expectations. Analyst sentiment is mixed with 38% buy ratings while the company executes strategic moves including AI partnerships and business portfolio optimization.
HSBC presents a balanced opportunity with solid profitability and strategic repositioning, but faces execution risks in its global restructuring. The current valuation at 16.37 P/E appears reasonable for a global bank, though regulatory challenges and market volatility require monitoring. Near-term catalysts include the upcoming Q2 earnings and continued progress on business simplification initiatives.
Humana (HUM) trades at $404.80, up 1.2% on the day, with a bullish technical signal and recent earnings beats. Revenue has grown steadily to $129.66 billion in 2025, though net income margin has compressed to 0.82%. The company is focused on margin recovery in its Medicare Advantage business and expanding its CenterWell healthcare services segment.
The stock faces headwinds from declining profitability and regulatory scrutiny, but analyst consensus leans Hold with a $354.33 price target below the current price. Upside depends on successful execution of its 2028 margin targets, while risks include healthcare cost pressures and potential legal challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →
